Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02091960
Title A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | ESP | CAN | BEL

Facility Status City State Zip Country Details
Site US10051 Anaheim California 92801 United States Details
Site US10028 Los Angeles California 90048 United States Details
Site US10035 San Francisco California 94115 United States Details
Site US10079 Fort Myers Florida 33916 United States Details
Site US10074 Gainesville Florida 32605 United States Details
Site US10081 Chicago Illinois 60637 United States Details
Site US10004 Indianapolis Indiana 46202 United States Details
Site US10070 Boston Massachusetts 02215 United States Details
Site US10078 Saint Louis Missouri 63110 United States Details
Site US10072 Cincinnati Ohio 45242 United States Details
Site US10048 Pittsburgh Pennsylvania 15213 United States Details
Site US10029 Knoxville Tennessee 37909 United States Details
Site US10042 Nashville Tennessee 37203 United States Details
Site US10077 Nashville Tennessee 37232 United States Details
Site US10076 Fort Worth Texas 76104 United States Details
Site US10082 Houston Texas 77030 United States Details
Site BE32003 Edegem Antwerp 2650 Belgium Details
Site BE32013 Brasschaat 2930 Belgium Details
Site BE32016 Bruxelles 1200 Belgium Details
Site BE32001 Charleroi 6000 Belgium Details
Site BE32009 Leuven 3000 Belgium Details
Site BE32007 Liege 4000 Belgium Details
Site CA15022 Ottawa Ontario K1H 8L6 Canada Details
Site CA15023 Toronto Ontario M4N 3M5 Canada Details
Site CA15028 Regina Saskatchewan S4T7T1 Canada Details
Site CA15026 Saskatoon Saskatchewan S7N 4H4 Canada Details
Site CA15001 Quebec G1S 4L8 Canada Details
Site IT39005 Meldola Forli 47014 Italy Details
Site IT39008 Lecce 73100 Italy Details
Site IT39002 Milano 20141 Italy Details
Site IT39003 Milan 20132 Italy Details
Site IT39001 Sondrio 23100 Italy Details
Site IT39021 Udine 33100 Italy Details
Site ES34014 Pozuelo de Alarcon Madrid 28223 Spain Details
Site ES34010 Barcelona 08035 Spain Details
Site ES34013 Madrid 28050 Spain Details
Site GB44003 Edinburgh EH4 2XU United Kingdom Details
Site GB44013 Manchester M20 4BX United Kingdom Details
Site GB44001 Nottingham NG5 1PB United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field